Patents Assigned to Fluoresentric, Inc
  • Publication number: 20170226576
    Abstract: Provided herein are dynamic flux nucleic acid sequence amplification methods. The dynamic flux nucleic acid sequence amplification methods described herein are capable of amplifying nucleic acid sequences within a narrow temperature range. In some aspects, the disclosure provides for real-time dynamic flux nucleic acid sequence amplification methods.
    Type: Application
    Filed: April 21, 2017
    Publication date: August 10, 2017
    Applicant: Fluoresentric, Inc.
    Inventor: Brian Erich Caplin
  • Publication number: 20170198342
    Abstract: Methods and reagents suitable for conducing polymerase chain reaction are described. In particular, a nucleic acid amplification design strategy and thermal cycling profile to enable efficient amplification of multiple nucleic acid targets along with improved sensitivity is disclosed. The present disclosure also describes methods and devices for increasing the melting temperature (Tm) of a primer.
    Type: Application
    Filed: July 10, 2015
    Publication date: July 13, 2017
    Applicant: Fluoresentric, Inc.
    Inventors: Brian CAPLIN, Brian HICKE, Bryson GREEN
  • Patent number: 9670531
    Abstract: Provided herein are dynamic flux nucleic acid sequence amplification methods. The dynamic flux nucleic acid sequence amplification methods described herein are capable of amplifying nucleic acid sequences within a narrow temperature range. In some aspects, the disclosure provides for real-time dynamic flux nucleic acid sequence amplification methods.
    Type: Grant
    Filed: April 26, 2016
    Date of Patent: June 6, 2017
    Assignee: Fluoresentric, Inc.
    Inventor: Brian Erich Caplin
  • Publication number: 20160230218
    Abstract: Provided herein are dynamic flux nucleic acid sequence amplification methods. The dynamic flux nucleic acid sequence amplification methods described herein are capable of amplifying nucleic acid sequences within a narrow temperature range. In some aspects, the disclosure provides for real-time dynamic flux nucleic acid sequence amplification methods.
    Type: Application
    Filed: April 26, 2016
    Publication date: August 11, 2016
    Applicant: Fluoresentric, Inc.
    Inventor: Brian Erich Caplin
  • Patent number: 9353408
    Abstract: Provided herein are dynamic flux nucleic acid sequence amplification methods. The dynamic flux nucleic acid sequence amplification methods described herein are capable of amplifying nucleic acid sequences within a narrow temperature range. In some aspects, the disclosure provides for real-time dynamic flux nucleic acid sequence amplification methods.
    Type: Grant
    Filed: August 13, 2015
    Date of Patent: May 31, 2016
    Assignee: Fluoresentric, Inc.
    Inventor: Brian Erich Caplin
  • Patent number: 9139882
    Abstract: Provided herein are methods for assaying a biological sample for microorganisms having drug resistant and/or drug sensitive phenotypes, wherein the methods are capable of detecting resistant and sensitive phenotypes associated with known and/or unknown mutations. In some aspects, methods are provided for detecting drug resistant Myobacterium tuberculosis (MTb), including multi-drug resistant MTb, wherein drug resistance is associated with one or more novel mutations. Also provided are systems, kits, and compositions related to such methods.
    Type: Grant
    Filed: November 22, 2010
    Date of Patent: September 22, 2015
    Assignee: Fluoresentric, Inc.
    Inventor: Brian Erich Caplin
  • Publication number: 20140026685
    Abstract: A chemical indicator device comprising a housing that comprises a viewing port, a means to provide illumination, and test tube wells so configured such that the observer views the test tubes from the side.
    Type: Application
    Filed: June 28, 2013
    Publication date: January 30, 2014
    Applicant: Fluoresentric, Inc
    Inventor: Brian Caplin